Zonisamide

Classification: Others

Cas NO.: 68291-97-4

Molecular Formula: C8H8N2O3S

Melting Point: 275°C dec.

Boiling Point: 457

Stability: null

Refractive index:

Flash Point: 230

Purity: 99%

Appearance: off-white powder

usage: synthesis of Zonisamide API

Brand Name: HRD

EINECS: 614-395-8

Aliase: 1-(1,2-Benzoxazol-3-yl)methanesulphonamide

Purity: 99%

Appearance:white crystalline powder

Brand: HRD

synthesis of Zonisamide API: anti-convulsant

Usage: Sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for

Packaging & Delivery

Packaging Detail: 25kg per drum or as per the requirment of customer

Delivery Detail: 5 days for ready stock, 3 weeks for order.

Detailed Description

Synonyms: 1-(1,2-Benzoxazol-3-yl)methanesulphonamide

Main Specifications:

Appearance: white crystalline powder

Assay: 99% Min. HPLC

Single Impurity: 0.5% Max.

Loss on Drying: 0.5% Max.

Heavy Metal: 20ppm Max.

Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunct therapy in adults with partial-onset seizures. Zonisamide is approved in the United States, United Kingdom, China, for adjunctive treatment of partial seizures in adults and in Japan for both adjunctive and monotherapy for partial seizures (simple,complex, secondarily generalized), generalized (tonic, tonic-clonic(grand mal), and atypical absence) and combined seizures.